HK1161098A1 - 用於治療叢集性頭痛症的方法和試劑盒 - Google Patents

用於治療叢集性頭痛症的方法和試劑盒

Info

Publication number
HK1161098A1
HK1161098A1 HK12101651.4A HK12101651A HK1161098A1 HK 1161098 A1 HK1161098 A1 HK 1161098A1 HK 12101651 A HK12101651 A HK 12101651A HK 1161098 A1 HK1161098 A1 HK 1161098A1
Authority
HK
Hong Kong
Prior art keywords
headche
kits
disorders
methods
treating cluster
Prior art date
Application number
HK12101651.4A
Other languages
English (en)
Inventor
約翰‧
‧哈爾佩恩
托爾斯滕‧哈里‧約翰內斯‧帕西
Original Assignee
Mclean Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mclean Hospital Corp filed Critical Mclean Hospital Corp
Publication of HK1161098A1 publication Critical patent/HK1161098A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK12101651.4A 2008-09-17 2012-02-20 用於治療叢集性頭痛症的方法和試劑盒 HK1161098A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9777308P 2008-09-17 2008-09-17
PCT/US2009/055971 WO2010033392A2 (en) 2008-09-17 2009-09-04 Methods and kits for treating cluster headache disorders

Publications (1)

Publication Number Publication Date
HK1161098A1 true HK1161098A1 (zh) 2012-08-24

Family

ID=42040074

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12101651.4A HK1161098A1 (zh) 2008-09-17 2012-02-20 用於治療叢集性頭痛症的方法和試劑盒

Country Status (11)

Country Link
US (2) US8415371B2 (zh)
EP (1) EP2331100B1 (zh)
JP (1) JP5690732B2 (zh)
CN (1) CN102164603B (zh)
BR (1) BRPI0918623A2 (zh)
CA (1) CA2737135C (zh)
GB (1) GB2475660B (zh)
HK (1) HK1161098A1 (zh)
IL (1) IL211714A (zh)
MX (1) MX2011002883A (zh)
WO (1) WO2010033392A2 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8859579B2 (en) 2008-03-21 2014-10-14 Richard Andrew Sewell Compostions and methods for preventing and/or treating disorders associated with cephalic pain
EP2331100B1 (en) * 2008-09-17 2014-07-16 The McLean Hospital Corporation Methods and kits for treating cluster headache disorders
JP2022525036A (ja) * 2019-03-07 2022-05-11 アーバーメンティス・エルエルシー 非サイケデリック／精神異常発現性の投与量及び製剤で投与される神経可塑性作用を有する物質を含む組成物並びに使用方法
WO2021195427A1 (en) * 2020-03-25 2021-09-30 Ch Tac, Llc 2-bromo-lysergic acid diethylamide for substance abuse
WO2022198315A1 (en) * 2021-03-22 2022-09-29 Betterlife Pharma Inc. Methods of treating mental and/or mood disorders using 2-bromo-lsd alone or in combination with a mtor inhibitor
CA3232914A1 (en) * 2021-09-20 2023-03-23 Blife Therapeutics Inc. Lsd derivatives, synthesis & method for treatment of diseases and disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3228959A (en) * 1962-01-16 1966-01-11 Geigy Chem Corp Quaternary salts of certain indolealkylamines and therapeutic uses thereof
US4524072A (en) * 1984-06-18 1985-06-18 Zivin Justin A Reduction of stroke damage
GB8618700D0 (en) * 1986-07-31 1986-09-10 Beecham Group Plc Compounds
DE3785507T2 (de) * 1986-07-31 1993-07-29 Beecham Group Plc Azabicyclische verbindungen, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
MXPA04008259A (es) * 2002-02-26 2005-05-27 Johnson & Johnson Co-terapia para el tratamiento de migrana que comprende derivados de un anticonvulsivo y agentes anti-migrana.
CA2529528A1 (en) 2003-06-20 2004-12-29 Ronald Aung-Din Topical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
US8859579B2 (en) * 2008-03-21 2014-10-14 Richard Andrew Sewell Compostions and methods for preventing and/or treating disorders associated with cephalic pain
EP2331100B1 (en) * 2008-09-17 2014-07-16 The McLean Hospital Corporation Methods and kits for treating cluster headache disorders

Also Published As

Publication number Publication date
EP2331100A2 (en) 2011-06-15
CN102164603B (zh) 2015-11-25
JP5690732B2 (ja) 2015-03-25
CA2737135C (en) 2017-07-11
WO2010033392A3 (en) 2010-06-17
JP2012502909A (ja) 2012-02-02
CA2737135A1 (en) 2010-03-25
GB2475660A (en) 2011-05-25
EP2331100B1 (en) 2014-07-16
BRPI0918623A2 (pt) 2015-12-01
WO2010033392A2 (en) 2010-03-25
MX2011002883A (es) 2011-04-21
US20130252996A1 (en) 2013-09-26
GB201104907D0 (en) 2011-05-04
US20110104275A1 (en) 2011-05-05
IL211714A (en) 2016-04-21
GB2475660B (en) 2013-04-17
IL211714A0 (en) 2011-06-30
US8415371B2 (en) 2013-04-09
CN102164603A (zh) 2011-08-24
EP2331100A4 (en) 2012-04-25

Similar Documents

Publication Publication Date Title
IL257418A (en) Methods for treating addiction
HK1212883A1 (zh) 治療眼部疾病的方法
EP2083857A4 (en) METHOD FOR TREATING INTERFERENCE IN CONNECTION WITH MICA
LT2894165T (lt) Būdai ir kompozicijos, skirti su komplementu susijusių sutrikimų gydymui
HK1155374A1 (zh) 用於治療炎性疾病和纖維變性疾病的化合物和方法
EP2170309A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES
GB2467710B (en) Methods for treating social disorders
EP2331088A4 (en) COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC ILLNESSES
IL213526A0 (en) Methods for treating acute myocardial infarctions and associated disorders
EP2323681A4 (en) METHODS OF TREATING VIRAL CONDITIONS
HK1203305A1 (zh) 治療牛皮癬的方法
EP2331097A4 (en) METHOD FOR TREATING CNS DISEASES
HK1161098A1 (zh) 用於治療叢集性頭痛症的方法和試劑盒
EP2249837A4 (en) METHOD FOR TREATING THROMBOEMBOLIC ILLNESSES
EP2219650A4 (en) COMPOSITIONS AND METHODS FOR TREATING FIBROPROLIFERATIVE DISORDERS
SI2201950T1 (sl) Spojine in metode za zdravljenje motenj avtističnega spektra
IL207906A0 (en) Treatment for ocular-related disorders
EP2124957A4 (en) METHOD FOR THE TREATMENT OF VITAL DISEASES
ZA200801796B (en) Methods for treating substance-related disorders
AU2008902365A0 (en) Methods for treating muscle disorders and improving muscle form
EP2373330A4 (en) METHOD FOR DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES
AU2008900382A0 (en) Method for treating B cell disorders
AU2008901029A0 (en) Methods for treating neurological disorders
ZA201000867B (en) Methods for treating dependence
GB0804427D0 (en) Methods and kits